Relation of Amiodarone Level with Total Protein Level in Blood Plasma of Covid 19 Hospitalized Patients with Ventricular Heart Arrythmia

Slavena Stoykova; Wladislav Tashkov

doi:10.59573/emsj.7(1).2023.20

Authors

Slavena Stoykova
Wladislav Tashkov

DOI:

https://doi.org/10.59573/emsj.7(1).2023.20

Keywords:

Sars-CoV2, Covid 19, ventricular arrythmia, total protein, Amiodarone, HPLC

Abstract

During Covid 19 global pandemic numerous patients were in urgent need of hospital treatment. Some of them had different known concomitant diseases, various accompanying conditions and comorbidities. Others with clean medical history developed all of a sudden severe complication because of the Sars-CV2 infection. Medical professionals of different fields, including ophthalmology, surgery, neurology, joined Covid 19 teams after urgent retainment. Patients enrolled in this study were hospitalized because of Covid 19 and needed treatment for ventricular arrythmia as well. Amiodarone blood tests were performed using an adapted HPLC method verified for over 10 years of continuous observations.

References

Baskin, L. B., & Hsu, R. M. (1999). Laboratory evaluation of proteinuria. MLO: medical laboratory observer, 31(11), 30–39.

Camara, P. D., Wright, C., Dextraze, P., & Griffiths, W. C. (1991). Comparison of a commercial method for total protein with a candidate reference method. Annals of clinical and laboratory science, 21(5), 335–339.

Dawnay, A. B., Hirst, A. D., Perry, D. E., & Chambers, R. E. (1991). A critical assessment of current analytical methods for the routine assay of serum total protein and recommendations for their improvement. Annals of clinical biochemistry, 28 (Pt 6), 556–567. https://doi.org/10.1177/000456329102800604

Gill, S. C., Moon-Mcdermott, L., Hunt, T. L., Deresinski, S., Blaschke, T., & Sandhaus, R. A. (1999). Phase I Pharmacokinetics of Liposomal Amikacin (MiKasome) in Human Subjects: Dose Dependence and Urinary Clearance. In Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother (Vol. 39, No. 33, pp. 527-36, abstract no. 1195).

Jacobs, D.S., DeMott, W.R., & Oxley, D.K. (2001). Laboratory Test Handbook (p. 269, 5th ed.). Lexi-Comp., Inc. Hudson (Cleveland), OH.

M?ntyj?rvi, M., Tuppurainen, K., & Ik?heimo, K. (1998). Ocular side effects of amiodarone. Survey of Ophthalmology, 42(4), 360–366. https://doi.org/10.1016/s0039-6257(97)00118-5

Ruiz-Garcia, A., Bermejo, M., Moss, A., & Casabo, V. G. (2008). Pharmacokinetics in drug discovery. Journal of pharmaceutical sciences, 97(2), 654–690. https://doi.org/10.1002/jps.21009

Stoykova, S. & Tashkov, W. (2015). Monitoring of Cordarone dosage variations by HPLC-UV detection in case of non-hospitalized patients. Comptes rendus de l’Academie bulgare des Sciences, 68(12), 1527-1532.

Stoykova, S. & Tashkov, W. (2016). Corneal changes due to the treatment with Amiodarone and their concentration with the plasma concentration of the medication when analyzed with HPLC. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 7(5), 2538-2542.

Weiner, D., & Gabrielsson, J. (2000). PK24 – Nonlinear kinetics - flow II. Pharmacokinetic/ pharmacodynamic data analysis: concepts and applications (pp. 527–36). Apotekarsocieteten.